Intersectoral cooperation to increase HPV vaccine coverage: an innovative collaboration between Managed Care Organizations and state-level stakeholders

被引:2
作者
Askelsono, Natoshia [1 ,2 ]
Ryan, Grace [1 ,2 ]
Seegmiller, Laura [1 ]
Preiss, Alexander [3 ]
Comstock, Sara [4 ]
机构
[1] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA
[2] Univ Iowa, Publ Policy Ctr, Iowa City, IA USA
[3] Amer Canc Soc, Raleigh, NC USA
[4] Amer Canc Soc, Des Moines, IA USA
关键词
Managed Care Organizations; intersectoral cooperation; HPV vaccination; cancer prevention; Medicaid; HUMAN-PAPILLOMAVIRUS VACCINATION; PROVIDER RECOMMENDATION; UNITED-STATES; HEALTH; INTERVENTIONS;
D O I
10.1080/21645515.2019.1694814
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In order to reduce disparities in human papillomavirus (HPV) vaccine coverage, intersectoral approaches are needed to reach vulnerable populations, including Medicaid enrollees. This manuscript describes a collaboration between Medicaid Managed Care Organizations (MCOs), the American Cancer Society, and a state health department in a Midwestern state to address HPV vaccination. Qualitative interviews (n = 11) were conducted via telephone with key stakeholders from the three participating organizations using an interview guide designed to capture the process of developing the partnership and implementing the HPV-focused project. Interviews were transcribed and coded using thematic analysis. Interviewees described motivation to participate, including shared goals, and facilitators, like pooled resources. They cited barriers, such as time and legal challenges. Overall, interviewees reported that they believed this project is replicable. Conducting this project revealed the importance of shared vision, effective communication, and the complementary resources and experiences contributed by each organization. Valuable lessons were learned about reaching the Medicaid population and groundwork was laid for future efforts to serve vulnerable populations and reduce health disparities. This work has significant implications for other organizations seeking to partner with large nonprofits, state health departments, MCOs, or others, and the lessons learned from this project could be translated to other groups working to improve vaccination rates in their communities.
引用
收藏
页码:1385 / 1391
页数:7
相关论文
共 34 条
  • [1] [Anonymous], 2006, Redefining healthcare
  • [2] The Triple Aim: Care, health, and cost
    Berwick, Donald M.
    Nolan, Thomas W.
    Whittington, John
    [J]. HEALTH AFFAIRS, 2008, 27 (03) : 759 - 769
  • [3] Redesigning Medicaid Managed Care
    Bindman, Andrew
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (15): : 1537 - +
  • [4] Predictors of HPV vaccine acceptability: A theory-informed, systematic review
    Brewer, Noel T.
    Fazekas, Karah I.
    [J]. PREVENTIVE MEDICINE, 2007, 45 (2-3) : 107 - 114
  • [5] Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial
    Brewer, Noel T.
    Hall, Megan E.
    Malo, Teri L.
    Gilkey, Melissa B.
    Quinn, Beth
    Lathren, Christine
    [J]. PEDIATRICS, 2017, 139 (01)
  • [6] A Quality Improvement Initiative to Increase HPV Vaccine Rates Using an Educational and Reminder Strategy With Parents of Preteen Girls
    Cassidy, Brenda
    Braxter, Betty
    Charron-Prochownik, Denise
    Schlenk, Elizabeth A.
    [J]. JOURNAL OF PEDIATRIC HEALTH CARE, 2014, 28 (02) : 155 - 164
  • [7] Centers for Disease Control and Prevention, 2018, NUMB HPV ASS CANC CA
  • [8] Centers for Disease Control and Prevention, 2017, AFIX ASS FEEDB INC E
  • [9] The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model
    Chesson, Harrell W.
    Markowitz, Lauri E.
    Hariri, Susan
    Ekwueme, Donatus U.
    Saraiya, Mona
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (06) : 1363 - 1372
  • [10] Community Preventive Services Task Force, 2019, GUID COMM PREV SERV